ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Pharmacophore model, docking, QSAR, and molecular dynamics simulation studies of substituted cyclic imides and herbal medicines as COX-2 inhibitors

Moussa, Nathalie*; Hassan, Ahmad*; Gharaghani, Sajjad
Heliyon2021-4DOI: 10.1016/j.heliyon.2021.e06605
16被引4阅读
引用收藏
分享

摘要

Cyclooxygenase-2 (COX-2) enzyme inhibitors have not eliminated the necessity for developed drugs not only in the nonsteroidal anti-inflammatory drug (NSAIDs) area, but also in other therapeutic applications including prevention of cancer and Alzheimer's disease. A series of novel substituted cyclic imides have been reported as selective COX-2 inhibitors. To understand the structural features responsible for their activity, a 3D validated pharmacophore and quantitative structure-activity relationship (QSAR) model have been developed. The values of enrichment factor (EF), goodness of hit score (GH), area under the ROC curve (AUC), sensitivity, and specificity refer to the good ability of the pharmacophore model to identify active compounds. Multiple linear regression (MLR) produced statistically significant QSAR model with (R-training(2) = 0.763, R-test(2) = 0.96) and predictability (Q(training)(2) = 0.66, Q(test)(2) = 0.84). Then, using the pharmacophore and QSAR models, eight authenticated botanicals in two herbal medicines and the ZINC compounds database, were virtually screened for ligands to COX-2. The retrieved hits which also obey lipinski's rule of five (RO5) were docked in the COX-2 3D structure to investigate their binding mode and affinity. Finally, based on the docking results, nine molecules were prioritized as promising hits that could be used as leads to discover novel COX-2 inhibitors. COX-2 inhibition of most of these hits has not been reported previously. Ten-nanosecond molecular dynamics simulation (10-ns MD) was performed on the initial structure COX-2 complex with ZINC000113253375 and ZINC000043170560 resulted from the docking. Our utilization of the 3D pharmacophore model, QSAR, molecular docking, and molecular dynamics simulation trials can be a potent strategy to successfully predict activity, efficiently design drugs, and screen large numbers of new compounds as active drug candidates.

学科与关键词

关键词
Cyclooxygenase-2DockingQSARPharmacophoreMolecular dynamics simulationVirtual screening
相关
加载中…
  • In vitro and In Silico Studies on Curcumin and Its Analogues as Dual Inhibitors for cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2)
    Nunung Yuniarti; Perdana Adhi Nugroho; Aditya Asyhar; Sardjiman Sardjiman; Zullies Ikawati; Enade Perdana IstyastonoITB Journal of Sciences, 2012, 44(1): 51-66.
  • Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities
    Kumar, Raj; Saha, Nirjhar; Purohit, Priyank; Garg, Sanjeev K.; Seth, Kapileswar; Meena, Vachan S.; Dubey, Sachin; Dave, Khyati; Goyal, Rohit; Sharma, Shyam S.; Banerjee, Uttam C.; Chakraborti, Asit K.*European Journal of Medicinal Chemistry, 2019, 182: 111601.被引 33
  • Synthesis of Acetaminophen-Based Coumarins as Selective COX-2 Inhibitors: An in vitro-in silico Study
    Jasim, Mahmood H. M.; Mustafa, Yasser Fakri*CHEMISTRY & BIODIVERSITY, 2024, 21(10): e202401309.
查看全部 →

发表信息

论文状态
公开发表
期刊
Heliyon
发表日期
2021-04
卷期
第 7 卷, 第 4 期
页码
e06605
DOI
10.1016/j.heliyon.2021.e06605
成果收录
SCIE

作者

  • M

    Moussa, Nathalie (通讯) (第一作者)

  • H

    Hassan, Ahmad (通讯)

查看全部 3 位作者收起作者
  • G

    Gharaghani, Sajjad

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417